Huntington's disease primarily damages the basal ganglia, especially the striatum, which includes the caudate nucleus and putamen, leading to severe neuron loss and atrophy. This damage disrupts movement, thinking, and emotion, also affecting the cerebral cortex, particularly in later stages, causing significant cognitive and behavioral issues.
Huntington disease is caused by gradual degeneration of parts of the basal ganglia called the caudate nucleus and putamen. The basal ganglia are collections of nerve cells located at the base of the cerebrum, deep within the brain.
In patients with Huntington's disease, neurons in a part of the brain called the striatum are among the hardest-hit. Degeneration of these neurons contributes to patients' loss of motor control, which is one of the major hallmarks of the disease.
Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder that prominently affects the basal ganglia, leading to affective, cognitive, behavioral and motor decline.
The researchers focused on the striatum, which is involved in regulating motor control, cognition, and emotion, because it is the brain region most affected by Huntington's disease.
Huntington's disease is a rare, inherited condition that slowly affects your movement and thinking abilities. A gene change causes damage in areas of your brain that control coordination, memory and emotions. Symptoms build over time.
The disease attacks areas of the brain that help to control voluntary (intentional) movement, as well as other areas. People living with HD develop uncontrollable dance-like movements (chorea) and abnormal body postures, as well as problems with behavior, emotion, thinking, and personality.
Huntington's disease results in the death of brain cells. The parts of the brain affected are the frontal lobe and basal ganglia. These are responsible for movement, thinking, personality and emotions.
Over many years, this “mutant” huntingtin protein forms clumps in brain cells, and causes them to become damaged and die. The most vulnerable part of the brain in HD is called the striatum, and it controls movement, mood, and memory. Damage to the striatum over time is what causes the symptoms of HD.
The cerebellum of all HD patients showed a considerable atrophy, as well as a consistent loss of Purkinje cells and nerve cells of the fastigial, globose, emboliform and dentate nuclei.
Central nervous system injuries
These injuries are often called traumatic brain injuries or traumatic spine injuries. Injured nerve cells in the central nervous system typically do not regenerate. However, this part of the nervous system can reorganize in response to an injury.
These movements typically affect several parts of the body, all at once, and can vary in terms of both their intensity and their frequency. Chorea is often related to an abnormality in the basal ganglia, a part of the brain that regulates voluntary motor control and movement coordination.
All patients with Huntington's disease exhibited significant brain atrophy resulting from volume reductions in both cortical and subcortical grey matter. Atrophy of the cortex was relatively uniform, although the medial temporal lobe structures were spared.
Brain-imaging tests can provide information on the structure or function of the brain. These tests may include MRI or CT scans that show detailed images of the brain. These images may reveal changes in the brain in areas affected by Huntington's disease. These changes may not show up early in the course of the disease.
Sydenham's chorea is a disorder characterized by rapid, uncoordinated jerking movements primarily affecting the face, hands and feet. It is a result of an autoimmune response that occurs following infection by group A β-hemolytic streptococci (GABHS) that destroys cells in the corpus striatum of the basal ganglia.
Huntington's disease (HD), also known as Huntington's chorea, is a fatal neurodegenerative disease that is usually inherited. It typically presents as a triad of progressive psychiatric, cognitive, and motor symptoms.
Abstract. Huntington's and Parkinson's disease are two movement disorders representing mainly opposite states of the basal ganglia inhibitory function.
Symptoms of Huntington's disease
Speech changes are typically mild initially but can get worse over time. Speech can become slurred (if muscles in the face and tongue become weak) or lose its natural rhythm and sound 'jerky' (if you have difficulty coordinating your breathing with speech).
To conclude neuroimaging, particularly MRI, remains a cornerstone in the diagnosis and assessing the severity of Huntington's disease. Genetic testing can be used to confirm the diagnosis if the family history is not forthcoming.
Early in the disease, cognitive decline may manifest as memory and learning difficulties, judgment impairment, and trouble with driving, answering questions or making decisions. As the disease progresses, concentration and focus on intellectual tasks become increasingly difficult.
Huntington's disease impairs the functioning of the brain, which can result in apathy, trouble organizing, impulsivity, irritability and anger, unawareness, disinhibition, preservation, and other psychiatric symptoms. These emotional and behavioral symptoms can further complicate the caregiver's role.
Huntington's disease targets cells in two brain regions for destruction: the cortex and the striatum. Far more neurons die in the striatum — a cerebral region named after its striped layers of gray and white matter.
And for social and cultural as well as medical and scientific reasons, it played a far more important role in defining the discrete clinical entity that soon came to be known as 'Huntington's chorea' and by the late 1960s, as 'Huntington's disease'.
Recent studies showed a hyperconnectivity between the cerebellum and the basal ganglia in premanifest children with expanded CAG repeats, as well as an enlargement of the cerebellum in adolescence-onset Huntington's disease.